News

Details

Published: 02 July 2020

• portfolio-news

Immatics (NASDAQ: IMTX) today announced the completion of its business combination with Arya Sciences Acquisition Corp. (NASDAQ: ARYA), a special purpose acquisition company (SPAC) sponsored by Perceptive Advisors. Today, Immatics will commence trading its shares under the symbol “IMTX” and its warrants under the symbol “IMTXW” on the Nasdaq Capital Market. Proceeds from this transaction were approximately $253 million, which included funds held in Arya’s trust account and the common stock private investment in public equity (PIPE) financing contributed by a group of leading US healthcare institutional investors. 

Details

Published: 02 July 2020

• portfolio-news

GTX Medical announced today the appointment of Dave Marver as CEO. Mr. Marver is a highly experienced medtech leader. He will guide GTX through the development and commercialization of its neuromodulation technologies to accelerate and improve the functional recovery of people with spinal cord injury (SCI). 

Details

Published: 01 July 2020

• portfolio-news

MChE / F4 Pharma and SIRS therapeutics announce promising results from treatment of six severely ill COVID-19 patients with FX06 under “named patient use”. By time of start of FX06 administration, all patients were treated in the ICU with mechanical ventilation, and five - in addition - received extracorporeal membrane oxygenation (ECMO). Within a few days following the FX06 treatment, all patients showed an improvement of lung function parameters and a significant reduction of inflammation markers.